During the past decade, Mrc/Uvri Uganda Research Unit On Aids conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 2 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 1 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mrc/Uvri Uganda Research Unit On Aids" #1 sponsor was "MRC/UVRI and LSHTM Uganda Research Unit" with 5 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials sponsored, "University of Oxford" with 2 trials sponsored, "International Partnership for Microbicides, Inc." with 1 trials sponsored and "Janssen Sciences Ireland UC" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mrc/Uvri Uganda Research Unit On Aids" #1 collaborator was "Department for International Development, United Kingdom" with 2 trials as a collaborator, "MRC/UVRI and LSHTM Uganda Research Unit" with 2 trials as a collaborator, "British Medical Research Council" with 1 trials as a collaborator, "CONRAD" with 1 trials as a collaborator and "Center for HIV/AIDS Vaccine Immunology" with 1 trials as a collaborator. Other collaborators include 22 different institutions and companies that were collaborators in the rest 32 trials.

According to Clinical.Site data, the most researched conditions in "Mrc/Uvri Uganda Research Unit On Aids" are "HIV Infections" (4 trials), "COVID" (1 trials), "COVID-19" (1 trials), "Covid19" (1 trials) and "Diabetes" (1 trials). Many other conditions were trialed in "Mrc/Uvri Uganda Research Unit On Aids" in a lesser frequency.

Most popular intervention types in "Mrc/Uvri Uganda Research Unit On Aids" are "Drug" (7 trials), "Biological" (4 trials), "Other" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Ad26.ZEBOV/MVA-BN-Filo" (1 trials), "Arm A: ABC+3TC+NNRTI" (1 trials), "Arm B: ZDV+ABC+3TC+NNRTI->ABC+3TC+NNRTI maintenance" (1 trials) and "Arm C: ZDV+ABC+3TC+NNRTI->ZDV+ABC+3TC maintenance" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mrc/Uvri Uganda Research Unit On Aids" are 12 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Mrc/Uvri Uganda Research Unit On Aids". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 7 completed trials in Mrc/Uvri Uganda Research Unit On Aids, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mrc/Uvri Uganda Research Unit On Aids, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".